NUVIGIL: A Treatment for Jet Lag?

Cephalon Inc, Frazer, Pa, plans to file a supplemental New Drug Application (sNDA) with the US Food and Drug Administration (FDA) to expand the indications for NUVIGIL® (armodafinil) Tablets. This comes after recent positive results from a phas

Sleep Problems Linked to Increased Risk of Suicidal Behaviors

Results of a recent study found that the more types of sleep disturbances a person has, the more likely they are to have thoughts of killing themselves, engage in planning a suicidal act, or make a suicide attempt. In the study, scientists exami

AASM Names New President Elect, Board of Directors

The American Academy of Sleep Medicine (AASM) completed the election of the 2009-2010 Board of Directors after receiving a total of 1,045 ballots. The election results are as follows: President Elect: Patrick Strollo, Jr, MD Director: Steven S

New Military Electronic Records to Be Model for US

by Jeff Mason Last Updated: 2009-04-09 19:25:43 -0400 (Reuters Health) President Barack Obama on Thursday said the government would create a national electronic medical records system for the military that will serve as a model for broad refo

May 12 Is National Fibromyalgia Awareness Day

In 1993, May 12 was designated as the International Awareness Day for Chronic Immunological and Neurological Diseases, to memorialize the birth date of Florence Nightingale, the English army nurse who inspired the founding of the International Red

Somaxon Meets with FDA to Discuss Next Step for Silenor

After the US Food and Drug Administration (FDA) raised issues in its Complete Response letter for the New Drug Application (NDA) for Silenor® for the treatment of insomnia, Somaxon Pharmaceuticals Inc, San Diego, met with the FDA to discuss the